Publicaciones (145) Publicaciones de ALFONSO CARVAJAL GARCIA PANDO

2021

  1. Association of CNR1 and INSIG2 polymorphisms with antipsychotics-induced weight gain: a prospective nested case–control study

    Scientific Reports, Vol. 11, Núm. 1

2018

  1. Only full adherence to proton pump inhibitors protects against drug-induced upper gastrointestinal bleeding

    European Journal of Clinical Pharmacology, Vol. 74, Núm. 11, pp. 1503-1511

2016

  1. CYP2C9 variants as a risk modifier of NSAID-related gastrointestinal bleeding: A case-control study

    Pharmacogenetics and Genomics, Vol. 26, Núm. 2, pp. 66-73

  2. Carpal tunnel syndrome associated with oral bisphosphonates. A population-based cohort study

    PLoS ONE, Vol. 11, Núm. 1

  3. Genetic variants associated with antithyroid drug-induced agranulocytosis: A genome-wide association study in a European population

    The Lancet Diabetes and Endocrinology, Vol. 4, Núm. 6, pp. 507-516

  4. Impact of regulatory measures on antipsychotics drug consumption in Castilla y León, Spain

    Public Health, Vol. 141, pp. 113-119

  5. Prescription patterns of antihypertensives in a community health centre in Mexico City: A drug utilization study

    Fundamental and Clinical Pharmacology, Vol. 30, Núm. 3, pp. 276-281

  6. Some other ideas about the future of pharmacovigilance

    Pharmacovigilance: Critique and Ways Forward (Springer International Publishing), pp. 31-33

2015

  1. Emergency contraceptive pill safety profile. Comparison of the results of a follow-up study to those coming from spontaneous reporting

    Pharmacoepidemiology and Drug Safety, Vol. 24, Núm. 1, pp. 93-97

  2. Guillain-Barré syndrome and influenza vaccines: A meta-analysis

    Vaccine, Vol. 33, Núm. 31, pp. 3773-3778

2014

  1. A European community pharmacy-based survey to investigate patterns of prescription fraud through identification of falsified prescriptions

    European Addiction Research, Vol. 20, Núm. 4, pp. 174-182

  2. Hepatotoxicity related to agomelatine and other new antidepressants: A case/noncase approach with information from the portuguese, French, Spanish, and Italian pharmacovigilance systems

    Journal of Clinical Psychopharmacology, Vol. 34, Núm. 3, pp. 327-330

  3. Knowledge upon the emergency contraceptive pill in Spain

    Atencion Farmaceutica, Vol. 16, Núm. 3, pp. 224-228

  4. Letter to the editor: Reporting problems related to medications in Spain. The yonotifco (I report) project, an option for citizens

    International Journal of Clinical Pharmacology and Therapeutics

  5. No differences between men and women in adverse drug reactions related to psychotropic drugs: A survey from France, Italy and Spain

    Fundamental and Clinical Pharmacology, Vol. 28, Núm. 3, pp. 342-348

2013

  1. Hip fracture rates and bisphosphonate consumption in Spain. An ecologic study

    European Journal of Clinical Pharmacology, Vol. 69, Núm. 3, pp. 559-564

  2. Illustration of the weibull shape parameter signal detection tool using electronic healthcare record data

    Drug Safety, Vol. 36, Núm. 10, pp. 995-1006

  3. Open-label evaluation of a novel skin brightening system containing 0.01% decapeptide-12 in combination with 20% buffered glycolic acid for the treatment of mild to moderate facial melasma

    Journal of Drugs in Dermatology, Vol. 12, Núm. 6

2012

  1. Antipsychotic drugs

    Side Effects of Drugs Annual (Elsevier B.V.), pp. 51-84

  2. Toward a clinical practice guide in pharmacogenomics testing for functional polymorphisms of drug-metabolizing enzymes. Gene/drug pairs and barriers perceived in Spain

    Frontiers in Genetics, Vol. 3, Núm. NOV